Skip to NavigationSkip to content

Senate Finance Comittee Chairman, Chuck Grassley calls on Novartis to reveal details of data scandal

Published on 13/08/19 at 04:08pm
Image Credit: Gage Skidmore

Chuck Grassley, Chairman of the Senate Finance Committee, has demanded that Novartis give up details on the faulty data scandal surrounding Zolgensma.

In a letter to Novartis CEO Vas Narismhan, Senator Grassley described the Swiss firm’s actions as “reprehensible” as he suggested that “the conduct ought to be investigated and, as appropriate, punished to the full extent of the law.”

The Iowa Senator thus called on Novartis to offer up information on:

  • All records relating to the withholding of Zolgensma data from the FDA
  • All records relating to Novartis’ internal inquiry into Zolgensma data manipulation
  • On what date did Novartis learn that it issued manipulated data to the FDA relating to Zolgensma?
  • On what date did Novartis open an internal inquiry into the manipulated data?
  • On what date did Novartis conclude the internal inquiry?
  • How many Novartis employees have been terminated for manipulating Zolgensma data? 
  • What steps have you taken to ensure that manipulated data is not sent to the FDA for future products?

Senator Grassley said this information should be put forward no later than 23 August 2019. Novartis said it had received Grassley’s letter and was now reviewing the request.

Senator Grassley’s letter follows that of five senators, including presidential candidates Bernie Sanders and Elizabeth Warren, to acting FDA commissioner Ned Sharpless, asking that the agency hold Novartis to account over the faulty Zolgensma data.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches